Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Net of Acquisitions & Divestments (2020 - 2026)

Cresco Labs' (CRLBF) quarterly Net of Acquisitions & Divestments came in at -$2.2 million in Q1 2026, down 4278.0% on a QoQ basis from -$50000.0 in Q2 2022.

Cresco Labs (CRLBF) Net of Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 4 years of Net of Acquisitions & Divestments data on file, last reported at -$2.2 million in Q1 2026.

  • Quarterly Net of Acquisitions & Divestments changed N/A year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 million (changed N/A YoY) and the FY2020 annual result came in at -$14.8 million, up 48.38% from the prior year.
  • Net of Acquisitions & Divestments declined to -$2.2 million in Q1 2026, from -$50000.0 in the prior quarter.
  • In the past five years, Net of Acquisitions & Divestments ranged from a high of -$50000.0 in Q2 2022 to a low of -$2.2 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn -
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn -
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Cresco Labs 295.09 Mn 230.98 Mn 86.95 Mn -1.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.19 Mn
Mar 31, 2026 -2.19 Mn
Jun 30, 2022 -50,000.00
Jun 30, 2022 -50,000.00
Mar 31, 2022 -1.09 Mn
Mar 31, 2022 -1.09 Mn
Sep 30, 2021 -19.05 Mn
Sep 30, 2021 -19.05 Mn
Jun 30, 2021 -2.69 Mn
Jun 30, 2021 -2.69 Mn
Mar 31, 2021 -140,000.00
Mar 31, 2021 -140,000.00
Dec 31, 2020 1.56 Mn
Dec 31, 2020 1.56 Mn
Mar 31, 2020 -13.45 Mn
Mar 31, 2020 -13.45 Mn